Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.56 USD | -2.15% | -2.77% | -30.38% |
May. 13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
Financials (USD)
Sales 2024 * | 28.34M | Sales 2025 * | 95.58M | Capitalization | 195M |
---|---|---|---|---|---|
Net income 2024 * | -68M | Net income 2025 * | -16M | EV / Sales 2024 * | 6.88 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.04 x |
P/E ratio 2024 * |
-3.05
x | P/E ratio 2025 * |
-11.2
x | Employees | 67 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.29% |
Latest transcript on Zevra Therapeutics, Inc.
1 day | -2.15% | ||
1 week | -2.77% | ||
Current month | -0.44% | ||
1 month | +0.88% | ||
3 months | -34.39% | ||
6 months | -6.94% | ||
Current year | -30.38% |
Managers | Title | Age | Since |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 06-10-29 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 23-10-09 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 23-04-24 |
Tamara Favorito
CHM | Chairman | 65 | 21-08-17 |
Douglas Calder
BRD | Director/Board Member | 56 | 23-04-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.44% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 4.56 | -2.15% | 199,380 |
24-05-24 | 4.66 | +3.79% | 164,760 |
24-05-23 | 4.49 | -3.02% | 200,199 |
24-05-22 | 4.63 | +0.22% | 113,914 |
24-05-21 | 4.62 | -1.49% | 146,244 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.38% | 195M | |
+16.34% | 79.03B | |
+8.65% | 8.78B | |
-16.33% | 4.83B | |
+51.22% | 4.65B | |
+2.18% | 3.89B | |
+20.51% | 2.34B | |
-26.79% | 2.18B | |
+15.12% | 2.11B | |
-36.56% | 2B |
- Stock Market
- Equities
- ZVRA Stock